Opinion: The 4 arguments you will hear against drug price negotiation

By The New York Times
| September 06, 2023

Here are some of the arguments you're likely to hear against drug price negotiation and the context necessary to evaluate them.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...